John T. Treace is a corporate insider, tracked as Chief Executive Officer, Director, 10% Owner of TREACE MEDICAL CONCEPTS, INC. (TMCI). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has John T. Treace submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has John T. Treace been buying or selling stock?
Recorded transactions: 14 open-market purchases ($1.45M) and 0 open-market sales across all tracked filings.
John T. Treace is Chief Executive Officer, Director, 10% Owner of TREACE MEDICAL CONCEPTS, INC. (TMCI). 9 SEC Form 4 filings on record, most recently on 24 August 2026. Most recent open-market trade: bought $48K of TMCI on 24 August 2026. Lifetime open-market purchases: $1.45M.
Recent transactions
19
The latest 19 SEC Form 4 transactions reported by John T. Treace.
InsiderAlpha's records for John T. Treace go back to 2026: 9 primary Form 4 filings, an average of 9.0 per year. The typical open-market purchase is $104K (14 buys totaling $1.45M). The largest single buy on record is $185K of TMCI in 2026. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
